Share this article Share this article ResearchAndMarkets.com's offering. Global revenues from RA drug sales are expected to grow from $26.2B in 2019 to $29.1B in 2029. The publisher projects that the global RA marketplace - which, for the purposes of this report, comprises eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia) - will grow at a compound annual growth rate (CAGR) of 1.0% over the 10-year forecast. Global growth in the RA market will be driven by continued uptake of new products in the IL-6 and JAK inhibitor classes along with ...